Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8745782 | Indian Journal of Tuberculosis | 2018 | 15 Pages |
Abstract
Nearly half of the multi drug resistant (MDR) tuberculosis patients (44.22%) being treated on category IV regimen also have resistance to either fluoroquinolones or aminoglycosides or both i.e. Pre XDR or XDR. This may result in poor outcome of category IV regimen under RNTCP. There is a strong need for provision of culture sensitivity for all first line drugs and at least two second line drugs viz. Fluoroquinolones and aminoglycosides for all the patients registered as smear positive under RNTCP. There is also a need for development of rapid culture technique for sensitivity to second line drugs.
Related Topics
Health Sciences
Medicine and Dentistry
Infectious Diseases
Authors
Amit Kumar Sharma, Neeraj Gupta, Dilip Kumar Kala, Tarun Patni, Ramakant Dixit, Satyadeep Verma, Arjun Chandran,